Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions |
Total |
Cumulative effect of changes in accounting principles, net of tax |
Number of shares of common stock [Member] |
Common stock and additional paid-in capital [Member] |
Accumulated deficit [Member] |
Accumulated deficit [Member]
Cumulative effect of changes in accounting principles, net of tax
|
Accumulated other comprehensive loss [Member] |
| Beginning Balance, Shares at Dec. 31, 2019 |
|
|
591.4
|
|
|
|
|
| Balance as of beginning of period at Dec. 31, 2019 |
$ 9,673
|
$ (2)
|
|
$ 31,531
|
$ (21,330)
|
$ (2)
|
$ (528)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
1,825
|
|
|
|
1,825
|
|
|
| Other comprehensive income (loss), net of taxes |
(134)
|
|
|
|
|
|
(134)
|
| Dividends declared on common stock |
(938)
|
|
|
|
(938)
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
0.9
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
10
|
|
|
10
|
|
|
|
| Stock-based compensation expense |
52
|
|
|
52
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(68)
|
|
|
(68)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(4.3)
|
|
|
|
|
| Repurchases of common stock |
(933)
|
|
|
|
(933)
|
|
|
| Ending Balance, Shares at Mar. 31, 2020 |
|
|
588.0
|
|
|
|
|
| Balance as of end of period at Mar. 31, 2020 |
9,485
|
|
|
31,525
|
(21,378)
|
|
(662)
|
| Beginning Balance, Shares at Dec. 31, 2019 |
|
|
591.4
|
|
|
|
|
| Balance as of beginning of period at Dec. 31, 2019 |
9,673
|
$ (2)
|
|
31,531
|
(21,330)
|
$ (2)
|
(528)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
5,649
|
|
|
|
|
|
|
| Ending Balance, Shares at Sep. 30, 2020 |
|
|
583.5
|
|
|
|
|
| Balance as of end of period at Sep. 30, 2020 |
10,959
|
|
|
31,713
|
(19,851)
|
|
(903)
|
| Beginning Balance, Shares at Mar. 31, 2020 |
|
|
588.0
|
|
|
|
|
| Balance as of beginning of period at Mar. 31, 2020 |
9,485
|
|
|
31,525
|
(21,378)
|
|
(662)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
1,803
|
|
|
|
1,803
|
|
|
| Other comprehensive income (loss), net of taxes |
(121)
|
|
|
|
|
|
(121)
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
1.0
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
65
|
|
|
65
|
|
|
|
| Stock-based compensation expense |
101
|
|
|
101
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(81)
|
|
|
(81)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(2.6)
|
|
|
|
|
| Repurchases of common stock |
(591)
|
|
|
|
(591)
|
|
|
| Other |
(2)
|
|
|
|
(2)
|
|
|
| Ending Balance, Shares at Jun. 30, 2020 |
|
|
586.4
|
|
|
|
|
| Balance as of end of period at Jun. 30, 2020 |
10,659
|
|
|
31,610
|
(20,168)
|
|
(783)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
2,021
|
|
|
|
2,021
|
|
|
| Other comprehensive income (loss), net of taxes |
(120)
|
|
|
|
|
|
(120)
|
| Dividends declared on common stock |
(952)
|
|
|
|
(952)
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
0.1
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
5
|
|
|
5
|
|
|
|
| Stock-based compensation expense |
109
|
|
|
109
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(11)
|
|
|
(11)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(3.0)
|
|
|
|
|
| Repurchases of common stock |
(752)
|
|
|
|
(752)
|
|
|
| Ending Balance, Shares at Sep. 30, 2020 |
|
|
583.5
|
|
|
|
|
| Balance as of end of period at Sep. 30, 2020 |
$ 10,959
|
|
|
31,713
|
(19,851)
|
|
(903)
|
| Beginning Balance, Shares at Dec. 31, 2020 |
578.3
|
|
578.3
|
|
|
|
|
| Balance as of beginning of period at Dec. 31, 2020 |
$ 9,409
|
|
|
31,802
|
(21,408)
|
|
(985)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
1,646
|
|
|
|
1,646
|
|
|
| Other comprehensive income (loss), net of taxes |
152
|
|
|
|
|
|
152
|
| Dividends declared on common stock |
(1,012)
|
|
|
|
(1,012)
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
0.7
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
6
|
|
|
6
|
|
|
|
| Stock-based compensation expense |
57
|
|
|
57
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(59)
|
|
|
(59)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(3.7)
|
|
|
|
|
| Repurchases of common stock |
(865)
|
|
|
|
(865)
|
|
|
| Ending Balance, Shares at Mar. 31, 2021 |
|
|
575.3
|
|
|
|
|
| Balance as of end of period at Mar. 31, 2021 |
$ 9,334
|
|
|
31,806
|
(21,639)
|
|
(833)
|
| Beginning Balance, Shares at Dec. 31, 2020 |
578.3
|
|
578.3
|
|
|
|
|
| Balance as of beginning of period at Dec. 31, 2020 |
$ 9,409
|
|
|
31,802
|
(21,408)
|
|
(985)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
$ 3,994
|
|
|
|
|
|
|
| Ending Balance, Shares at Sep. 30, 2021 |
565.0
|
|
565.0
|
|
|
|
|
| Balance as of end of period at Sep. 30, 2021 |
$ 8,217
|
|
|
31,989
|
(22,964)
|
|
(808)
|
| Beginning Balance, Shares at Mar. 31, 2021 |
|
|
575.3
|
|
|
|
|
| Balance as of beginning of period at Mar. 31, 2021 |
9,334
|
|
|
31,806
|
(21,639)
|
|
(833)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
464
|
|
|
|
464
|
|
|
| Other comprehensive income (loss), net of taxes |
(35)
|
|
|
|
|
|
(35)
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
0.8
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
47
|
|
|
47
|
|
|
|
| Stock-based compensation expense |
100
|
|
|
100
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(76)
|
|
|
(76)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(6.5)
|
|
|
|
|
| Repurchases of common stock |
(1,592)
|
|
|
|
(1,592)
|
|
|
| Other |
5
|
|
|
|
5
|
|
|
| Ending Balance, Shares at Jun. 30, 2021 |
|
|
569.6
|
|
|
|
|
| Balance as of end of period at Jun. 30, 2021 |
8,247
|
|
|
31,877
|
(22,762)
|
|
(868)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income for basic and diluted EPS |
1,884
|
|
|
|
1,884
|
|
|
| Other comprehensive income (loss), net of taxes |
60
|
|
|
|
|
|
60
|
| Dividends declared on common stock |
(1,017)
|
|
|
|
(1,017)
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs, Shares |
|
|
0.0
|
|
|
|
|
| Issuance of common stock in connection with the Company’s equity award programs |
9
|
|
|
9
|
|
|
|
| Stock-based compensation expense |
111
|
|
|
111
|
|
|
|
| Tax impact related to employee stock-based compensation expense |
(8)
|
|
|
(8)
|
|
|
|
| Repurchases of common stock, Shares |
|
|
(4.6)
|
|
|
|
|
| Repurchases of common stock |
$ (1,069)
|
|
|
|
(1,069)
|
|
|
| Ending Balance, Shares at Sep. 30, 2021 |
565.0
|
|
565.0
|
|
|
|
|
| Balance as of end of period at Sep. 30, 2021 |
$ 8,217
|
|
|
$ 31,989
|
$ (22,964)
|
|
$ (808)
|